2025 PainConnect2025-03-28T19:56:56-04:00

The AAPM Annual Meeting is Now:

Lead. Innovate. Heal.

Transforming Pain Care Together

PainConnect offers a patient-centered approach to pain care tailored to meet the diverse needs of healthcare professionals. PainConnect fosters a dynamic learning environment, emphasizing holistic care and innovation. Join us to transform pain care through interdisciplinary collaboration and compassionate patient care. The meeting is held at the Hilton Austin.

05 days 03 hours 57 minutes 36 seconds
Lead, Innovate, Heal

Key Features of the 2025 Austin Event:

Innovative
Approach

Explore the Innovation Hub for the latest in pain care including interactive workshops, expert panels, and the 4th Annual AAPM+MIT Innovation Challenge.

Collaborative
Focus

Join a diverse network of pain management experts from various specialties, working together to enhance patient outcomes through interdisciplinary teamwork.

Patient-Centered
Focus

Learn from real-life patient cases and multidisciplinary strategies in our grand rounds sessions designed to optimize patient care and treatment outcomes.

Networking/Career
Advancement

Connect on a human level and advance your career through varied networking opportunities including Special Interest Groups, resident programs, and exclusive meet-ups with leaders in the field.

Who Should Attend?

PainConnect is for healthcare professionals seeking to lead the future of pain care. Together, we can innovate, heal, and revolutionize pain medicine.

  • Anesthesiologists/Pain Medicine Specialists

  • Behavioral Medicine Professionals

  • Emergency Medicine Physicians

  • Primary Care Providers

  • Internal Medicine Specialists

  • Residents and Fellows

  • Advanced Practice Providers

OUR KEYNOTE SPEAKERS

Peter Goadsby, FMedSci, FRS

Director, NIHR King’s Clinical Research Facility

Peter Goadsby obtained his medical degree and training at the University of New South Wales (UNSW), Australia. Neurology training was with James W. Lance and clinical neurophysiology with David Burke. After post-doctoral work in New York with Don Reis at Cornell, Jacques Seylaz at Universite VII, Paris, and post-graduate neurology training at Queen Square, London with C David Marsden, Andrew Lees, Anita Harding and W Ian McDonald, he returned to UNSW, and the Prince of Wales Hospital, Sydney as a consultant neurologist and became an Associate Professor of Neurology. He was appointed a Wellcome Senior Research Fellow at the Institute of Neurology, University College London in 1995. He was Professor of Clinical Neurology and Honorary Consultant Neurologist at the National Hospital for Neurology and Neurosurgery, Queen Square, London until 2007.

He has been Professor of Neurology, Department of Neurology, University of California, San Francisco since 2007. He has been an Honorary Consultant Neurologist at the Hospital for Sick Children, Great Ormond St, London since 1998.

In 2013 he was appointed Director, NIHR-Wellcome Trust King’s Clinical Research Facility, King’s College Hospital, Professor of Neurology at King’s College London and Honorary Consultant Neurologist, King’s College Hospital.

His major research interests are in the basic mechanisms of primary headache disorders, such as migraine and cluster headache, in both experimental and clinical settings, and translating these insights into better management.

Don’t miss the keynote presentation at 8:00 AM on April 4th in Salon C “Bench to Bedside—New Understanding and Better Treatment for Migraine,” highlighting advances in migraine pathophysiology and therapies.

Stephen G. Waxman, MD, PhD

Bridget Flaherty Professor of Neurology, Neuroscience and Pharmacology at Yale University

Stephen Waxman is the Bridget Flaherty Professor of Neurology, Neuroscience and Pharmacology at Yale University, where he served as Chairman of Neurology from 1986 until 2009. He founded and directs Yale’s Neuroscience & Regeneration Research Center. Prior to Yale, he held faculty positions at Harvard, MIT, and Stanford.

Dr. Waxman’s research capitalizes on the “molecular revolution” to develop new therapies that restore function after nervous system injury. He has published more than 800 scientific papers. His H-index is 126 and his papers have been cited more than 60,000 times.

Dr. Waxman’s first paper in Nature was published in 1970. His subsequent papers in Science, PNAS and Nature defined the ion channel architecture of nerve fibers, and demonstrated its importance for axonal conduction. He discovered the sodium channel plasticity that supports recovery of impulse conduction in demyelinated axons, both in animal models and within the human CNS in MS. Using molecular genetics, molecular biology, and biophysics, he made a molecule-to-man translational leap from laboratory to humans that uncovered the role of ion channels in human pain. He then led an international team that identified sodium channel mutations as causes of peripheral neuropathy. He has used atomic-level modeling to advance pharmacogenomics in a study, accompanied by a JAMA editorial stating “there are few examples in clinical medicine where molecular reasoning has been rewarded with comparable success”. A new class of non-addictive pain medications, based largely on his work as described in NEJM and the New York Times, is in Phase II/III clinical trials. He is now pinpointing “pain resilience” genes. His latest study in Nature characterizes an ion channel that controls joint degeneration in osteoarthritis.

Waxman has authored Spinal Cord Compression and Clinical Neuroanatomy (translated into 8 languages). He has served on multiple editorial boards including Annals of Neurology, Brain, Journal of Physiology, Trends in Molecular Medicine, and Nature Reviews Neurology. He is the Editor of The Neuroscientist. His trainees lead research teams throughout the world.

Dr. Waxman is a member of the National Academy of Medicine, and served on the Board of Scientific Counselors of NINDS. His honors include the Dystel Prize and Wartenberg Award (Amer. Acad. of Neurology), the Middleton Award and Magnuson Award (Veterans Admin), and the Soriano Award (Amer. Neurol. Assn). He was honored with the British Physiological Society’s Annual Prize, an accolade he shares with his heroes Nobel Prize laureates Andrew Huxley, John Eccles, and Alan Hodgkin. Most recently, he received the Mitchell Max Award (Amer. Acad. of Neurology), and the Julius Axelrod Prize (Society for Neuroscience).

Don’t miss the keynote presentation at 1:30 PM on April 5th in Salon C “Huxley’s Science Fiction: Ion Channels in Pain, Pain Resilience and Beyond,” exploring molecular mechanisms of pain and non-addictive treatments.

FEATURED SPEAKER

Maia Szalavitz

New York Times Bestselling Author and Opinion Writer

Maia Szalavitz is the author, most recently, of Undoing Drugs:  How Harm Reduction is Changing the Future of Drugs and Addiction, which is the first history of harm reduction in drug policy.

Her New York Times bestseller, Unbroken Brain: A Revolutionary New Way of Understanding Addiction wove together neuroscience and social science with her personal experience of addiction.  It won the 2018 media award from the National Institute on Drug Abuse.

She is a contributing opinion writer for the New York Times and has written for numerous publications including TIME, Wired, the Nation, Vice and Scientific American.

Her 2006 book, Help at Any Cost: How the Troubled Teen Industry Cons Parents and Hurts Kids, was the first to expose the damage caused by “tough love” youth treatment and helped spur Congressional hearings.

She has also authored or co-authored five other books, including the classic on child trauma, The Boy Who Was Raised as a Dog, with Dr. Bruce D. Perry.  With Dr. Perry, she has also written Born for Love:  Why Empathy Is Essential— And Endangered, which laid out why empathy is essential for social trust and how inequality can erode it.  With Dr. Joseph Volpicelli, she wrote Recovery Options:  The Complete Guide, the first evidence-based guide to addiction treatment.

She lives with her husband and two squeaky cats in New York City.

Twitter:  @maiasz

SCHEDULED SPEAKERS

MARIE
HANNA, MD

SALMAN
HIRANI, MD

BETH
HOGAN, MD

ROBERT
HURLEY, MD, PHD

KELLIE
JAREMKO, MD, PHD

Latest News

Go to Top